Skip to main content
Caris Life Sciences10-K: Market expansion

Expanding platform beyond oncology into cardiology, neurology, and metabolic conditions

Source

SEC EDGARMar 3, 2026

Annual report (Form 10-K)

Caris Life Sciences 10-K for FY2025

Filing excerpt

Capitalize on the ultimate potential of Caris Detect, our WGS, blood-based solution in development, and broader innovation platform in other chronic disease states beyond oncology, including in cardiology, neurology, and metabolic conditions.

sec.gov/Archives/edgar/data/2019410/000201941026000016/cai-20251231.htmRead the full source

Other signals in this filing (11)

Extracted by Autobound

From the Signal API record
Signal
10-K: Market expansion

What this signalsFilings often name leadership changes, deals and spending plans.

Period
FY2025
Fiscal year end
12/31
Filed
Mar 3, 2026

More 10-K signals at other companies

The full record

From the Signal API record

Details

CIK
2019410
Accession number
0002019410-26-000016
Filing year
2026
Why it matters
Scaling infrastructure needed

Topics and mentions

Technologies

  • WGS

Extraction

Confidence
High
Relevance
85%
Sentiment
Positive
Detected
Mar 10, 2026
signal_type
sec-10k
signal_subtype
marketExpansion

Use this data

Get every 10-K signal for Caris Life Sciences and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Caris Life Sciences this week?”

  2. Send it to your own tools

    The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/c7ecfda6-d479-4322-9667-d18dcca91e5a returns this record as JSON. POST /v1/companies/enrich returns every signal for carislifesciences.com.

{
  "signal_id": "c7ecfda6-d479-4322-9667-d18dcca91e5a",
  "signal_type": "sec-10k",
  "signal_subtype": "marketExpansion",
  "detected_at": "2026-03-10T06:44:07.681+00:00",
  "company": {
    "name": "Caris Life Sciences",
    "domain": "carislifesciences.com"
  },
  "data": {
    "detail": "This strategic expansion into new chronic disease states will require new research partnerships, data models, and potentially different regulatory and commercial pathways, creating opportunities for specialized vendors and platform providers.",
    "summary": "Expanding platform beyond oncology into cardiology, neurology, and metabolic conditions",
    "excerpts": "Capitalize on the ultimate potential of Caris Detect, our WGS, blood-based solution in development, and broader innovation platform in other chronic disease states beyond oncology, including in cardiology, neurology, and metabolic conditions.",
    "relevance": 0.85,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/2019410/000201941026000016/cai-20251231.htm",
    "filing_date": "2026-03-03",
    "filing_year": 2026,
    "fiscal_year_end": "12/31",
    "sales_relevance": "Scaling infrastructure needed",
    "signal_category": "market",
    "technologies_mentioned": [
      "WGS"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.